$TLX

$9.03 +$0.04 (0.44%) Close

$TLX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 338.8M shares outstanding

Who owns TLX?

By type of holder

Institutions 0.9% Insiders 0.0% Everyone else 99.1%

Concentration Top 10 holders own 0.6%

FMR LLC 0.2% · Portolan Capital Management, LLC 0.0%

Institutional ownership

0.9%

+0.2 pts vs last qtr

Institutional holders

+22 vs last qtr

Net shares bought

+608.7K

by institutions in Q2 2026

New / sold out

24 / 2

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Marshall Wace, LLP NEW +189.2K
Hennion & Walsh Asset Management, Inc. NEW +150.1K

Biggest sellers in Q2 2026

Portolan Capital Management, LLC −515.8K
Schonfeld Strategic Advisors LLC SOLD OUT −34.9K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Telix Pharmaceuticals Ltd in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Telix Pharmaceuticals Ltd.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years37% Under 1 year63%

Quarterly turnover

34.8%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting TLX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
F FMR LLC	561.2K	0.17%	−3.6K (−0.6%)	2025	0.0%
Shares held by quarter Peak holding564.8K (Q1'26) Change over 8 quarters+561.2K Share of the company0.170% FMR LLC's full portfolio →
PC Portolan Capital Management, LLC	25.4K	0.01%	−515.8K (−95.3%)	Q1 '26	0.0%
Shares held by quarter Peak holding541.3K (Q1'26) Change over 8 quarters+25.4K Share of the company0.010% Portolan Capital Management, LLC's full portfolio →

FMR LLC

561.2K

% of company

0.17%

Change vs last qtr

−3.6K (−0.6%)

Held since

2025

Portolan Capital Management, LLC

25.4K

% of company

0.01%

Change vs last qtr

−515.8K (−95.3%)

Held since

Q1 '26

25 more super investors behind a free account

See every manager holding Telix Pharmaceuticals Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting TLX on Form N-PORT; together they hold 0.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SA Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II	$4.1M	434.7K	0.13%	0.00%	May 31, 2026
AI ActivePassive International Equity ETF Trust for Professional Managers	$96.5K	8.7K	0.00%	0.01%	August 31, 2026

Strategic Advisers U.S. Total Stock Fund

Fidelity Rutland Square Trust II

Position value

$4.1M

% of company

0.13%

% of the fund

0.00%

As of

May 31, 2026

ActivePassive International Equity ETF

Trust for Professional Managers

Position value

$96.5K

% of company

0.00%

% of the fund

0.01%

As of

August 31, 2026

3 more funds behind a free account

See every fund holding Telix Pharmaceuticals Ltd and how much of the fund the position is.

Comments